How Does the New Definition of Epilepsy Differ from the Previous Version?
December 5th 2016Jacqueline A. French, MD—professor of neurology, NYU Comprehensive Epilepsy Study Consortium, president, The Epilepsy Study Consortium—discusses how the new ILAE definition of epilepsy and classification of seizures differ from the previous versions.
How Will the New Definition of Epilepsy Change the Landscape of the Disease?
December 5th 2016Jacqueline A. French, MD—professor of neurology, NYU Comprehensive Epilepsy Study Consortium, president, The Epilepsy Study Consortium—discusses how the new ILAE definition of epilepsy may change the disease.
How Can the New Definition of Epilepsy Improve Patient Outcomes?
December 5th 2016Jacqueline A. French, MD—professor of neurology, NYU Comprehensive Epilepsy Study Consortium, president, The Epilepsy Study Consortium—discusses how the new ILAE definition of epilepsy can improve patient outcomes.
What Is Tuberous Sclerosis Complex and How Does It Relate to Epilepsy?
December 3rd 2016Elizabeth Thiele, MD, PhD--pediatric neurologist/epileptologist, director, The Carol and James Herscot Center for Children and Adults with TSC, Massachusetts General Hospital--discusses tuberous sclerosis complex.
What Challenges Exist for Health Care Professionals in Implementing Vaccine Recommendations?
November 23rd 2016Gary Marshall, MD, professor of pediatrics at the University of Louisville School of Medicine, discusses the challenges health care professionals face in implementing vaccine recommendations.
How to Capture Data to Improve Specialty Pharmacy Operations
November 21st 2016John Campo, vice president of Pharmacy Trade Relations and Contracting at Managed Health Care Associates discusses how specialty stakeholders can accurately encapsulate the high volume of data they produce to improve operations.
Patient Management in the New Era of Specialty Pharmacy
November 15th 2016Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, senior director of Specialty Clinical Services at Managed Health Care Associates, discusses how specialty stakeholders will need to alter current patient management programs as new drugs transform the treatment of diseases into more manageable conditions.
Pharmacy Week in Review: November 11, 2016
November 11th 2016This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more. Our Week in Review is a can't miss for the busy pharmacy professional. This week, we welcome guest anchor Terri Warholak, PhD, RPh, CPHQ, FAPhA, who is an associate professor at The University of Arizona College of Pharmacy.